Aquaship / Intership has 700 employees, with operations in Chile, Scotland, Ireland, Canada and Norway.
The new vessel, with a well capacity of 4000 m³, will be the 41st vessel in the company's fleet and will have a significant battery pack, as well as a specially designed reverse osmosis system.
"This boat will be a fantastic addition to what is already one of the world's most modern fleets," said Ole Peter Brandal, CEO of Aquaship / Intership, in a press release.
"We see and hear what our customers need, and we invest in boats that meet both today's and tomorrow's demands. There are new and ever-increasing requirements for fish health, fish welfare, and environmental and climate emissions. I am proud that we are investing in the best wellboats on the market that deliver on these aspects," he added.
The new vessel is designed by Norwegian Salt Ship Design and built by the Spanish shipyard Zamakona in Bilbao, which has previously built two wellboats for the company.
"It requires a great deal of knowledge and experience to build state-of-the-art wellboats. We work with partners we know well and who we know deliver the best available technology on the market. The boat will also have lots of Norwegian equipment," said Brandal.
Freshwater treatments
Aquaship / Intership has been a leader in the development of freshwater treatment for lice and amoebic gill disease (AGD) using reverse osmosis for many years. The company has accumulated extensive operational experience from freshwater production and treatment. The new boat will have a large reverse osmosis system with a capacity of 10,000 m³ per day, as well as being prepared for combination treatment.
"With this system, we can fill the boat with self-produced freshwater in half a day. The treatment scores very well on all welfare indicators, and the fish start feeding immediately after treatment. This provides economic, welfare, and environmental benefits," said Brandal.
